|
The U.S. Food and Drug Administration (FDA) has placed pseudoephedrine (the active ingredient in most decongestants) in risk category C. This means that although there are no studies linking the loss of pregnancy or birth defects to pseudoephedrine use in humans, there is evidence of an increased risk in some animal studies. Pregnant women should not take pseudoephedrine without first consulting their physician. In addition, women who become pregnant while taking the drug should alert their physician immediately.
The American Academy of Pediatrics approves the use of pseudoephedrine in breastfeeding mothers because the drug is secreted into breast milk in very low doses (less than 1 percent). However, pseudoephedrine is believed to cause a decreased milk supply in some breastfeeding mothers. Women who experience this effect should drink plenty of fluids to compensate and consult their physician if they are concerned their child is not receiving enough milk.
|